Status: Not yet recruiting
Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin
This study aims to assess the cardioprotective effect of melatonin and vitamin D in breast cancer patients who receive doxorubicin.
Participants needed: 90
Trial details
Age: 18-65Biological sex: FemaleType: InterventionalSponsor: Tanta UniversityUpdated: Jan 16, 2026Locations: 1
Eligibility criteria
Age from 18 to 65 years old. [+5]
Pregnant or breastfeeding women. [+6]